Another medtech developer’s plans to create digital therapeutics to treat a wide range of illnesses are clicking into place, thanks to a third multimillion-dollar investment in Click Therapeutics in barely a year. [Read more…] about Click Therapeutics raises further $52M to build up digital therapeutics pipeline for depression, insomnia, smoking cessation and more
“Digital therapeutic company Akili Interactive has announced the first results of an open-label, multisite pediatric ADHD trial providing some patients with the company’s video game-like treatment alongside a stimulant medication.
According to the company, both those who received the AKL-T01 therapy with (n = 130) or without (n = 76) accompanying stimulant medication saw significant improvements one month after [Read more…] about Will digital therapeutics complement or replace stimulant medications to address inattention and “silent” cognitive issues?
“Akili Labs has kicked off open enrollment for a clinical trial of its Project EVO video game platform in a quest to secure for 510(k) clearance from the U.S. Food and Drug Administration for its lead indication [Read more…] about Large multi-center study to test videogame-like digital therapy as (potentially) FDA-cleared ADHD treatment
Happy to share that Dr. Lathan, CEO of AnthroTronix, will discuss the brand-new 510(k) FDA clearance of their DANA neurocognitive test at the 2014 SharpBrains Virtual Summit (October 28–30th), during the session Best practices to assess and enhance brain function via mobile devices and wearables.
Dr. Corinna Lathan leads AnthroTronix, a biomedical engineering product development company and pioneer in mobile platform technology. Their DANA™ product is [Read more…] about AnthroTronix CEO Corinna Lathan to discuss 510(k) FDA clearance of its DANA neurocognitive test at 2014 SharpBrains Virtual Summit